Kidney transplant patients get genetic check for hidden cancer risks
NCT ID NCT05298904
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests kidney transplant patients for genetic mutations that raise the risk of cancer and other diseases. Researchers want to see how common these mutations are and if testing helps guide better cancer screening. About 177 participants from Mayo Clinic are involved, all of whom have received a kidney or kidney-pancreas transplant.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help tailor cancer screening for kidney transplant patients based on their genetic risk.
- What could go wrong
- This is an observational study, not a treatment trial. It only measures genetic mutations and may not directly improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
177 people
The number who actually took part.
- Started
-
Mar 2022
- Expected to finish
-
Mar 2038
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants will be identified internally to Mayo Clinic Arizona via the kidney transplant program within one-year post transplant.
- Ages
-
18 to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: \- Post transplant Kidney and Kidney Pancreas recipients. Exclusion Criteria: * Simultaneous Liver Kidney Transplant. * Simultaneous Heart Kidney Transplant. * Non renal transplant history.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Kidney transplant are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic Arizona
Scottsdale, Arizona, 85259, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New fluid aims to keep donated kidneys healthier
- Can a phone app and a coach keep a new kidney healthier?
- A new tool aims to predict and prevent living kidney donor Drop-Out
- Can digital tools and training help more kidney patients get transplants?
- Can a new preservation fluid keep donor kidneys healthier for transplant?
- Oxygen bath for donor kidneys: a new hope for transplant success?